Clinical Pediatric Endocrinology

About CPE

Clinical Pediatric Endocrinology (CPE), which is published quarterly, is the official Journal of the Japanese Society for Pediatric Endocrinology. The first issue (Vol. 1, No. 1) was released in 1992, and 29 volumes have been, regularly and continuously, published to date.

CPE accepts articles for publication on the understanding that they contribute to the progress of the field of clinical endocrinology and metabolism applicable from infancy through adolescence.

CPE has become an exclusively on-line journal from January issue of 2020 (Vol. 29, No. 1).

SCImago Journal & Country Rank

Scopus (SJR)

CPE is indexed in the following databases:

On submission, an associate editor first decides if the manuscript should be rejected without review or sent for peer review. If the manuscript is sent for peer review, the associate editor will select one or more reviewer(s) and then make a decision on the deposition of the manuscript. The average times to first and final decisions are 22.18 and 44.90 days (as of January, 2022), respectively.

icon

Editor-in-Chief: Tatsuhiko Urakami, MD, PhD

urakami

Professor, Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan


Relevant Memberships and Positions:

  • 1. Specialist and Medical Advisor for Diabetes, The Japan Diabetes Society and The Japan Association for Diabetes Education and Care
  • 2. Chairperson of the Committee of Pediatric Diabetes, The Japan Diabetes Society
  • 3. Director and Councilor, The Japanese Society for Pediatric Endocrinology
  • 4. Member of ISPAD, Advisory Council during 2007-2009
  • 5. Convener of ISPAD Science School for physicians in 2012 and 2018
  • 6. Associate Editor, Pediatric Endocrinology Reviews
  • 7. Editor, Pediatric Diabetes
  • 8. Adjunct Professor, University of Indonesia
  • 9. Member of ISPAD, ADA, ESPE and APPES, etc.

Research Interests:

My research interests include epidemiology, pathology, diagnosis, and treatment in all kinds of diabetes. I am also interested in childhood obesity and associated metabolic disorders. I contribute to ISPAD activities, including the writing group of ISPAD Consensus Clinical Practice Guidelines 2007, 2014, 2018 (chapters of insulin treatment and type 2 diabetes) and ISPAD Science School for physicians.

icon

Vice Editor-in-Chief: Maki Fukami, MD, PhD

fukami

Director, Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan


Relevant Memberships and Positions:

  • 1. Director and Councilor, the Japanese Society of Pediatric Endocrinology
  • 2. Director and Councilor, Japan Society of Reproductive Endocrinology
  • 3. Councilor, the Japan Society of Human Genetics
  • 4. Councilor, the Japan Endocrine Society
  • 5. Chair, Endocrine Project in the Japan Environment and Children’s Study
  • 6. Visiting professor, Tohoku University
  • 7. Visiting professor, Tokyo Medical and Dental University
  • 8. Chief-Editor, the Japanese Journal of Reproductive Endocrinology
  • 9. Associate Editor, Molecular Syndromology
  • 10. Editor, Molecular Cellular Pediatrics
  • 11. Editor, Hormone Research in Pediatrics

Research Interests:

I am working on genomic, genetic, and epigenetic alterations associated with congenital endocrine disorders. Research topics of my lab include growth, sexual development, puberty, and fertility.

icon

Vice Editor-in-Chief: Toshimi Michigami, MD, PhD

michigami

Head, Department of Bone and Mineral Research, Research Institute, Osaka Women’s and Children’s Hospital, Osaka, Japan


Relevant Memberships and Positions:

  • 1. Councilor, The Japanese Society for Pediatric Endocrinology
  • 2. Councilor, The Japan Endocrine Society
  • 3. Councilor, The Japanese Society for Bone and Mineral Research
  • 4. Guest Professor, Osaka University
  • 5. Associate Editor, Journal of Bone and Mineral Metabolism
  • 6. Editor, Endocrine Journal
  • 7. Member of ASBMR, APPES, etc.

Research Interests:

My research interest is focused on better understanding of pathogenesis of skeletal dysplasias, disorders of calcium and phosphate metabolism, and diseases with impaired skeletal growth. I also aim to contribute to the improvement of diagnosis and management of these diseases.